The effect of short-chain fatty acids on human monocyte-derived dendritic cells
Open accessThe DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
The gut microbiota is essential for human health and plays an important role in the pathogenesis of several diseases. Short-chain fatty acids (SCFA), such as acetate, butyrate and propionate, are end-products of microbial fermentation of macronutrients that distribute systemically via the blood. The aim of this study was to investigate the transcriptional response of immature and LPS-matured human monocyte-derived DC to SCFA. Our data revealed distinct effects exerted by each individual SCFA on gene expression in human monocyte-derived DC, especially in the mature ones. Acetate only exerted negligible effects, while both butyrate and propionate strongly modulated gene expression in both immature and mature human monocyte-derived DC. An Ingenuity pathway analysis based on the differentially expressed genes suggested that propionate and butyrate modulate leukocyte trafficking, as SCFA strongly reduced the release of several pro-inflammatory chemokines including CCL3, CCL4, CCL5, CXCL9, CXCL10, and CXCL11. Additionally, butyrate and propionate inhibited the expression of lipopolysaccharide (LPS)-induced cytokines such as IL-6 and IL-12p40 showing a strong anti-inflammatory effect. This work illustrates that bacterial metabolites far from the site of their production can differentially modulate the inflammatory response and generally provides new insights into host-microbiome interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Short-chain fatty acids (SCFAs), such as acetate, butyrate, and propionate, produced by commensal bacteria during starch fermentation, strongly modulate gene expression in human monocyte-derived DCs, thus reducing the secretion of multiple proinflammatory chemokines and inhibiting the expression of LPS-induced cytokines with enhanced activity against inflammation (110).”
From Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy (2020) · cites this paper as [110]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,266
(2023) · doi:10.1126/science · Cited by 6,063
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C., Rolph, M. S., Mackay, F., Artis, D., et al. (2009) · Nature · doi:10.1038/nature08530 · Cited by 3,241
Short chain fatty acids in human large intestine, portal, hepatic and venous blood
Cummings, J. H., Pomare, E. W., Branch, W. J., Naylor, C. P., & Macfarlane, G. T. (1987) · Gut · doi:10.1136/gut.28.10.1221 · Cited by 3,119
Topping, D. L., & Clifton, P. M. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1031 · Cited by 3,091
Gut Microbiota Metabolism of Dietary Fiber Influences Allergic Airway Disease and Hematopoiesis
Trompette, A., Gollwitzer, E. S., Yadava, K., Sichelstiel, A. K., Sprenger, N., Ngom-Bru, C., Blanchard, C., Junt, T., Nicod, L. P., Harris, N. L., et al. (2014) · Nature Medicine · doi:10.1038/nm.3444 · Cited by 2,862
Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,822
The role of short chain fatty acids in health and disease
Tan, J., McKenzie, C., Potamitis, M., Thorburn, A. N., Mackay, C. R., & Macia, L. (2014) · Advances in immunology · doi:10.1016/b978-0-12-800100-4.00003-9 · Cited by 2,425
Cited by
Items 201–300 of 430
Huang, S., Gao, Y., Wang, Z., Yang, X. Y., Wang, J., & Zheng, N. (2022) · Food Science & Nutrition · doi:10.1002/fsn3.2682 · Cited by 30
Antibiotic-mediated dysbiosis leads to activation of inflammatory pathways
Taitz, J., Tan, J., Ni, D., Potier‐Villette, C., Grau, G. E., Nanan, R. K. H., & Macia, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1493991 · Cited by 37
The molecular signaling of exercise and obesity in the microbiota-gut-brain axis
Ribeiro, F. M., Silva, M. A., Lyssa, V., Marques, G., Lima, H. K., Franco, O. L., & Petriz, B. A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.927170 · Cited by 30
Hasan, M., Oster, M., Reyer, H., Wimmers, K., & Fischer, D. (2023) · British Journal Of Nutrition · doi:10.1017/s0007114523000442 · Cited by 28
Microbiota substances modulate dendritic cells activity: A critical view
Shvets, Y. V., Khranovska, N., Senchylo, N., Ostapchenko, D., Tymoshenko, I., Onysenko, S., Kobyliak, N. M., & Falalyeyeva, T. M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27125 · Cited by 28
“The molar ratio of acetate, propionate, and butyrate production in the healthy colon is approximately 60:25:15, respectively [28].”
BackgroundInfluentialSexual dimorphism in colorectal cancer: molecular mechanisms and treatment strategies
Rodríguez-Santiago, Y., Garay-Canales, C. A., Castro, K. E. N., & Morales‐Montor, J. (2024) · Biology of Sex Differences · doi:10.1186/s13293-024-00623-1 · Cited by 28
“For example, butyrate promotes an immunosuppressive microenvironment by enhancing the polarization of macrophages toward the M2 phenotype, reducing the production of proinflammatory cytokines by dendritic cells, and increasing the number of regulatory T cells in vivo [125, 126].”
BackgroundDumitru, I. G., Todor, S. B., Ichim, C., Helgiu, C., & Helgiu, A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14092982 · Cited by 27
“Moreover, in geriatric individuals, a reduction in SCFAs promotes age-related inflammation in the intestines; not only are SCFAs one of the most important metabolites for cell metabolism, but they also facilitate the generation of extrathymic regulatory T (Treg) cells and cytokine production [7,8].”
The gut microbiota and its metabolites: novel therapeutic targets for inflammatory bowel disease
Shen, X. Z., Li, Y., Wang, D., & Sun, K. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1690279 · Cited by 31
Yu, Q., Xu, J., Yan, C., Jin, H., Xiao, T., Yan, N., Zhou, L. H., An, H., Zhou, X., Shao, Q., et al. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.12990 · Cited by 29
The intricate connection between diet, microbiota, and cancer: A jigsaw puzzle
Arkan, M. C. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.08.009 · Cited by 32
Role of Micronutrients and Gut Microbiota-Derived Metabolites in COVID-19 Recovery
Hernández-Flores, T. D. J., Pedraza‐Brindis, E. J., Cárdenas-Bedoya, J., Ruíz-Carrillo, J. D., Méndez-Clemente, A. S., Martinez-Guzman, M. A., & Íñiguez-Gutiérrez, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012324 · Cited by 25
Exploring the effects of dietary inulin in rainbow trout fed a high-starch, 100% plant-based diet
Defaix, R., Lokesh, J., Frohn, L., Béchec, M. L., Pigot, T., Véron, V., Surget, A., Biasutti, S., Terrier, F., Cassy, S., et al. (2024) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-023-00951-z · Cited by 27
“Furthermore, SCFAs play an important role in regulating the integrity of the epithelial barrier of the intestinal in mucosa [19], and have anti-inflammatory functions [20, 21].”
BackgroundPostbiotics: Novel Modulators of Gut Health, Metabolism, and Their Mechanisms of Action
Farahani, H. E., Pourhajibagher, M., Asgharzadeh, S., & Bahador, A. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10832-8 · Cited by 36
“Butyrate and propionate regulate DC gene expression and influence T-cell polarization [ 109].”
The Function of Probiotics and Prebiotics on Canine Intestinal Health and Their Evaluation Criteria
Xia, J., Cui, Y., Guo, Y., Liu, Y., Deng, B., & Han, S. (2024) · Microorganisms · doi:10.3390/microorganisms12061248 · Cited by 26
“SCFAs can regulate T cell differentiation and function [28,29,78], promote B cell differentiation and intestinal IgA responses [79], and induce antimicrobial activity and phagocytic activity of macrophages. can regulate immune cells and intestinal in fl ammation through GPCRs signaling and…”
BackgroundBacterial Metabolites and Inflammatory Skin Diseases
Jiminez, V. S., & Yusuf, N. (2023) · Metabolites · doi:10.3390/metabo13080952 · Cited by 23
Yu, X., Dai, Z., Cao, G., Cui, Z., Zhang, R., Xu, Y., Wu, Y., & Yang, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1140564 · Cited by 27
“Butyrate and propionate can suppress the LPS-induced cytokines expression like IL12 and IL-6, displaying potent anti-inflammatory properties (66).”
BackgroundTLR ‐Stimulated Eosinophils Mediate Recruitment and Activation of NK Cells In Vivo
O'Flaherty, S. J., Sutummaporn, K., Häggtoft, W. L., Worrall, A. P., Rizzo, M., Braniste, V., Höglund, P., Kadri, N., & Chambers, B. J. (2017) · Scandinavian Journal of Immunology · doi:10.1111/sji.12554 · Cited by 24
Kapoor, M. P., Koido, M., Kawaguchi, M., Timm, D. A., Ozeki, M., Yamada, M., Mitsuya, T., & Ōkubo, T. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104067 · Cited by 25
Göttert, S., Orberg, E. T., Fan, K., Heinrich, P., Matthe, D. M., Khalid, O., Klostermeier, L., Suriano, C., Strieder, N., Gebhard, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65180-6 · Cited by 24
Wilson, K. R., Gressier, E., McConville, M. J., & Bedoui, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.897462 · Cited by 23
“Transcriptional interrogation of moDCs activated in the presence or absence of butyrate or propionate has also revealed significant reductions in the expression of chemokines including CXCL9, CXCL10, CXCL11 and CCL5 (104).”
BackgroundInfluentialRossouw, C., Ryan, F. J., & Lynn, D. J. (2024) · FEBS Journal · doi:10.1111/febs.17241 · Cited by 26
“In an in vitro model, butyrate and propionate have been shown to signifi-cantly reduce the expression of IL-6, a critically important cytokine for mounting immune responses, by human monocyte derived DCs [132].”
Clements, S. J., Maijó, M., Ivory, K., Nicoletti, C., & Carding, S. R. (2017) · Frontiers in Nutrition · doi:10.3389/fnut.2017.00065 · Cited by 23
Targeting the tumor immune microenvironment with “nutraceuticals”: From bench to clinical trials
Masuelli, L., Benvenuto, M., Focaccetti, C., Ciuffa, S., Fazi, S., Bei, A., Miele, M. T., Piredda, L., Manzari, V., Modesti, A., et al. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107700 · Cited by 24
Microbiota metabolites affect sleep as drivers of brain‑gut communication (Review)
Cheng, H. Y., Yang, W., Xu, H., Zhu, W., Gong, A., Yang, X., Li, S., & Xu, H. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5571 · Cited by 23
Perdijk, O., van Neerven, R. J. J., van den Brink, E., Savelkoul, H. F. J., & Brugman, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200356 · Cited by 25
Immunomodulatory Properties of Carvone Inhalation and Its Effects on Contextual Fear Memory in Mice
Lasarte-Cía, A., Lozano, T., Pérez-González, M., Gorraiz, M., Iribarren, K., Hervás‐Stubbs, S., Sarobe, P., Rabal, O., Cuadrado‐Tejedor, M., García‐Osta, A., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00068 · Cited by 22
“However, there are also reports assigning an immunosuppressive role to butyric acid in in vitro assays (24, 25), whereas in our hands, when it is inhaled, it could be considered immunostimulatory.”
BackgroundMicrobiota-dependent modulation of intestinal anti-inflammatory CD4+ T cell responses
Edwards, M., & Brockmann, L. (2025) · Seminars in Immunopathology · doi:10.1007/s00281-025-01049-6 · Cited by 21
“Butyrate induces tolerogenic cDCs through binding to G protein-coupled receptors (GPCRs) like GPR41, GPR43, and GPR109A [ 29, 89] —although the role of GPR109A has been debated [27 , 90]—and acting as an histone deacetylase (HDAC1, HDAC3) inhibitor, modulating gene expression through epigenetic…”
Causative Microbes in Host-Microbiome Interactions
Britton, G. J., & Faith, J. J. (2021) · Annual Review of Microbiology · doi:10.1146/annurev-micro-041321-042402 · Cited by 23
Ding, Y., Fang, Y., Pan, Y., Lan, J., Xu, T., Zhang, W., Mao, H., Gu, Z., Chen, X., & Shen, Q. (2023) · Food & Function · doi:10.1039/d2fo02463b · Cited by 21
In vitro and in vivo fermentation models to study the function of dietary fiber in pig nutrition
Huangfu, W., Cao, S., Li, S., Zhang, S., Liu, M., Liu, B., Zhu, X., Cui, Y., Wang, Z., Zhao, J., et al. (2024) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-024-13148-9 · Cited by 21
“SCFAs also directly activate the mammalian target of the rapamycin pathway in intestinal B cells, increase glucose uptake and glycolytic activity, and promote B cell differentiation into sIgA-producing plasma cells (Nastasi et al. 2015).”
Oral tolerance: Recent advances on mechanisms and potential applications
Sricharunrat, T., Pumirat, P., & Leaungwutiwong, P. (2019) · Asian Pacific Journal of Allergy and Immunology · doi:10.12932/ap0848 · Cited by 22
Habiballah, D. N., Li, F., & Jiang, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1602235 · Cited by 20
Wang, H., Chen, Y., Zhao, A., Shen, Z., & Zhang, Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1709060 · Cited by 21
Soluble fibre as a treatment for inflammation in asthma
Williams, L. M., Scott, H. A., & Wood, L. G. (2019) · Journal of Nutrition & Intermediary Metabolism · doi:10.1016/j.jnim.2019.100108 · Cited by 19
Immunomodulation of Avian Dendritic Cells under the Induction of Prebiotics
Zmrhal, V., & Sláma, P. (2020) · Animals · doi:10.3390/ani10040698 · Cited by 19
Vázquez‐Madrigal, C., Lopez, S., Grao‐Cruces, E., Millán-Linares, M. C., Rodríguez-Martín, N. M., Martín, M. E., Álba, G., Santa‐María, C., Bermúdez, B., & la Paz, S. M. (2020) · Nutrients · doi:10.3390/nu12103139 · Cited by 18
“The experimental use of primary human DCs is limited by their rarity in peripheral blood (less than 1% of MNCs), so to avoid this, in vitro moDCs are generally selected as a pragmatic model [30].”
BackgroundMattiola, I., & Diefenbach, A. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101724 · Cited by 19
Wu, X., Li, Q., Lin, D., Cai, J., Huang, H., & Tan, H. (2023) · Aging · doi:10.18632/aging.205019 · Cited by 19
The Infant Microbiome and Its Impact on Development of Food Allergy
Jungles, K. N., Jungles, K. M., Greenfield, L. R., & Mahdavinia, M. (2021) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2021.01.004 · Cited by 19
Ghimire, S., Weber, D., Hippe, K., Meedt, E., Hoepting, M., Kattner, A.-S., Hiergeist, A., Gessner, A., Matos, C., Ghimire, S., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.753287 · Cited by 17
“Upon treatment with SCFA, invitro generated mDCs showed increased expression of GPR109A and GPR43 followed by reduced pro-inflammatory IL-12 and an increase in anti-inflammatory IL-10 cytokine release pointing towards the immunoregulatory phenomenon of SCFA and are in line with previous reports where bacterial metabol…”
ResultSatapathy, P., Khan, K., Devi, A. T., Patil, A. G., Govindaraju, A. M., Gopal, S., Prasad, M. N. N., More, V. S., Kakarla, R. R., Raghu, A. V., et al. (2019) · Methods in microbiology · doi:10.1016/bs.mim.2019.02.001 · Cited by 18
Mutual interaction of microbiota and host immunity during health and diseases
Wu, D., Zhang, Y., Dong, S., & Zhong, C. (2021) · Biophysics Reports · doi:10.52601/bpr.2021.200045 · Cited by 17
“…DCs. Acetate, butyrate, and propionate could inhibit the expression of costimulatory molecules (CD80, CD86 and CD40) on DCs. They also repressed the production of several pro-inflammatory chemokines and cytokines (Iraporda et al. 2015; Nastasi et al. 2015).”
Cao, S., Budina, E., Wang, R., Sabados, M., Mukherjee, A., Solanki, A., Nguyen, M., Hultgren, K., Dhar, A., & Hubbell, J. A. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.06.027 · Cited by 16
Yang, M., Cai, C., Yang, Z., Wang, X., Li, G., Li, J., Liu, J., & Zhang, Z. (2024) · Food & Function · doi:10.1039/d4fo02221a · Cited by 18
Chandra, S., & Vassar, R. J. (2024) · Immunological Reviews · doi:10.1111/imr.13412 · Cited by 19
“30,31 SCFA can also regulate the functions of other pro-inflammatory immune cell populations, such as innate lymphoid cells 32,33 (ILCs), dendritic cells 34,35 (DCs), and B-cells.”
Lipidomic-Based Advances in Diagnosis and Modulation of Immune Response to Cancer
Gil‐de‐Gómez, L., Balgoma, D., & Montero, O. (2020) · Metabolites · doi:10.3390/metabo10080332 · Cited by 16
“The anti-inflammatory properties of SCFAs are also related to the ability of butyrate and propionate to abrogate IL-12 release from APCs, a cytokine with a primary role in effector T cell stimulation [76,77].”
BackgroundGonzalez-Mercado, V. J., Lim, S. J., Saligan, L. N., Perez, N. B., Rodriguez, C. S., Bernabe, R. D., Ozorio, S., Pedro, E., Sepehri, F., & Aouizerat, B. E. (2021) · Depression Research and Treatment · doi:10.1155/2021/7967552 · Cited by 18
“As such, besides bacterial abundances, SCFAs may be useful as potential biomarkers for the assessment of depression [71] and as potential therapeutic antiinflammatory agents [73, 74] for depression [75].”
BackgroundZhou, Y., Luo, Y., Yu, B., Zheng, P., Yu, J., Huang, Z., Mao, X., Luo, J., Yan, H., & He, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810290 · Cited by 17
“Butyrate and propionate can suppress human monocyte derived DC activation by inhibiting the LPS-induced expression of the costimulatory molecule CD40 and secretion of IL-6 and IL-12p40 [24].”
BackgroundDifferential responses of human dendritic cells to metabolites from the oral/airway microbiome
Whiteson, K., Agrawal, S., & Agrawal, A. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.12943 · Cited by 16
Ding, Y., Lan, J., Fang, Y., Pan, Y., Gu, Z., Xue, J., Yang, Y., Jiang, M., Ge, Y., & Shen, Q. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300373 · Cited by 16
Metabolites: deciphering the molecular language between DCs and their environment
Minarrieta, L., Ghorbani, P., Sparwasser, T. D., & Berod, L. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0609-6 · Cited by 17
Diet‐microbiota crosstalk and immunity to helminth infection
Myhill, L. J., & Williams, A. R. (2023) · Parasite Immunology · doi:10.1111/pim.12965 · Cited by 16
Yi, J., Lin, P., Li, Q., Zhang, A., & Kong, X. (2023) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2023.08.010 · Cited by 17
Zamani, M. M., Nikbaf‐Shandiz, M., Aali, Y., Rasaei, N., Zarei, M., Shiraseb, F., & Asbaghi, O. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1084084 · Cited by 16
Shih, L.-C., Lin, R.-J., Chen, Y., & Fu, S. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-023-00587-w · Cited by 19
“Acetate, butyrate, and propionate can also regulate intestinal in fl ammation by suppressing pro-in fl ammatory cytokine production 61 – 63 .”
BackgroundJardou, M., Brossier, C., Marquet, P., Picard, N., Druilhe, A., & Lawson, R. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1342354 · Cited by 14
Li, J., Xu, Y., Sun, T., Zhang, X., Liang, H., Lin, W. S., Yu, H., Yang, B., & Yang, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1430356 · Cited by 18
Fallahi, N., Rafiee, M., Hosseini, S. S., Sereshki, N., Sarab, G. A., & Erfanian, N. (2025) · Letters in Applied Microbiology · doi:10.1093/lambio/ovaf091 · Cited by 15
Chronic stress, gut microbiota, and immunity: interconnections and implications for health
Jia, H., Guo, X., Wei, Y., Can, C., He, N., Zhang, H., Yang, X., Wu, H., Liu, W., & Ma, D. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05376-y · Cited by 15
“…of bone-marrow-derived DCs (BMDC) The SCFAs suppressing the LPS-mediated expression of co-stimulatory molecules and the production of cytokines [218] Gut microbiota induce tolerogenic DCs (tDCs) AhR activation mediated by Trp-metabolit induces tDCs [219] Regulatory T Cells (Tregs) Gut…”
Schofield, Z., Wu, M. C. L., Hansbro, P. M., Cooper, M. A., & Woodruff, T. M. (2020) · The FASEB Journal · doi:10.1096/fj.202000960r · Cited by 14
Fan, Y., Forgie, A. J., Ju, T., Marcolla, C. S., Inglis, T., McMullen, L. M., Willing, B. P., & Korver, D. R. (2022) · Applied and Environmental Microbiology · doi:10.1128/aem.00295-22 · Cited by 14
“expression of cytokines and chemokines (19).”
BackgroundAkkerman, R., Logtenberg, M. J., Beukema, M., de Haan, B. J., Faas, M. M., Zoetendal, E. G., Schols, H. A., & de Vos, P. (2022) · Food & Function · doi:10.1039/d2fo00550f · Cited by 15
Resistance mechanisms to programmed cell death protein 1 and programmed death ligand 1 inhibitors
Pezeshki, P. S., Sharif, P. M., & Rezaei, N. (2021) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2021.1929919 · Cited by 14
“For example, Short-chain fatty acids such as butyrate and propionate that are the end-product of fermentative bacteria in the gut flora can modulate gene expression in dendritic cells and further inhibit the secretion of pro-inflammatory chemokines such as CCL3, CCL4, CCL5, chemokine (C-X-C motif) ligand 9 (CXCL9), CX…”
BackgroundAkkerman, R., Logtenberg, M. J., Beukema, M., de Haan, B. J., Faas, M. M., Zoetendal, E. G., Schols, H. A., & de Vos, P. (2021) · Food & Function · doi:10.1039/d1fo00893e · Cited by 13
An Update on the Mutual Impact between SARS-CoV-2 Infection and Gut Microbiota
Li, S., Zhou, Y., Yan, D., & Wan, Y. (2022) · Viruses · doi:10.3390/v14081774 · Cited by 14
“They can also strongly reduce the release of several proinflammatory chemokines through regulatory T cells, including CCL3, CCL4, CCL5, CXCL9, CXCL10, and CXCL11 [114].”
BackgroundShaping immunity: the influence of the maternal gut bacteria on fetal immune development
Faas, M. M., & Smink, A. M. (2025) · Seminars in Immunopathology · doi:10.1007/s00281-025-01039-8 · Cited by 13
“They also influence innate immune cells, such as dendritic cells and macrophages [169, 170].”
The role of dietary fibre in lung inflammation: microbiota, metabolites, and immune crosstalk
Azeez, A., & Baugh, J. A. (2025) · Inflammation Research · doi:10.1007/s00011-025-02098-1 · Cited by 13
“In addition to maturation and activation, MoDCs activated in the presence of butyrate (1 mM) and propionate (1 mM) showed inhibited expression of LPS-induced cytokines such as IL-6 and IL12p40, suggesting a strong anti-inflammatory effect [99].”
Association between Intestinal Microecological Changes and Atherothrombosis
Zhuo, X., Luo, H., Lei, R., Lou, X., Bian, J., Guo, J., Luo, H., Zhang, X., Jiao, Q., & Gong, W. (2023) · Microorganisms · doi:10.3390/microorganisms11051223 · Cited by 13
“Furthermore, propionic acid and butyric acid have been shown to antagonize the production of LPS-induced cytokines IL-6 and IL-12p40 in humans [79].”
BackgroundLi, J., Zhang, M., Zhang, Z.-D., Pan, X., Pan, L., & Sun, J. T. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01242-7 · Cited by 13
“Previous research has demonstrated that SCFAs suppress the expression of pro-in fl ammatory cytokines in dendritic cells (DCs) [11, 12].”
InfluentialBioactive lipids: Chemistry, biochemistry, and biological properties
Salsinha, A. S., Machado, M., Rodríguez-Alcalá, L. M., Gomes, A., & Pintado, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824043-4.00014-2 · Cited by 23
Andrzejczak, K., Kucharczyk, E., Sternak, A., Busłowicz, T., & Ponikowska, M. (2026) · Cells · doi:10.3390/cells15070594 · Cited by 12
The cytokine MIF controls daily rhythms of symbiont nutrition in an animal–bacterial association
Koch, E. J., Bongrand, C., Bennett, B. D., Lawhorn, S., Moriano‐Gutierrez, S., Pende, M., Vadiwala, K., Dodt, H., Raible, F., Goldman, W. E., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016864117 · Cited by 12
“toward short-chain fatty acids (SCFAs) as a response both to potential pathogens and beneficial microbiota (84, 85).”
BackgroundHan, X., Zang, D., Liu, D., & Chen, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.988849 · Cited by 12
“Butyrate and propionate regulate gene expression and lymphocyte recruitment in DC since SCFAs strongly reduce the release of several pro-inflammatory chemokines (118).”
BackgroundWells, R. K., Kunihiro, B. P., Phankitnirundorn, K., Peres, R., McCracken, T., Umeda, L., Lee, R. H., Kim, D. Y., Juárez, R., & Maunakea, A. K. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1035641 · Cited by 13
“, 2022) and systemic inflammation (Nastasi et al., 2015; Wen and Duffy, 2017; Scheithauer et al., 2020), suggested in reducing T2DM risk.”
BackgroundRadiation Therapy and the Microbiome; More Than a Gut Feeling
Amit, U., Facciabene, A., & Ben‐Josef, E. (2023) · The Cancer Journal · doi:10.1097/ppo.0000000000000650 · Cited by 11
“In general, SCFAs have anti-inflammatory effects on immune cells.(63,64)Many supporting studies have shown reduced expression of proinflammatory cytokines, such as tumor necrosis factor α, IL-6, and IL-12 by macrophages and DCs due to SCFAs.”
BackgroundAssociation between carbohydrate-to-fiber ratio and the risk of periodontitis
Liu, W., Zhang, W., & Ye, M. (2023) · Journal of Dental Sciences · doi:10.1016/j.jds.2023.04.012 · Cited by 23
“23,24 Subgroup analysis revealed that low carbohydrate-to-fiber ratio was associated with reduced risk of periodontitis in people aged (cid:1) 65 years.”
BackgroundThe influence of the gut microbiota on B cells in autoimmune diseases
He, L., Li, X., Jiang, S., Ou, Y., Wang, S., Shi, N., Yang, Z., Yuan, J., Silverman, G. J., & Niu, H. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01195-5 · Cited by 11
“On the other hand, gut microbiota can also influence cytokine production in antigen-presenting cells, e.g., short-chain fatty acid butyrate, a metabolite derived from gut microbiota, can act on DCs and macrophages to modulate cytokine/chemokine production (Nastasi et al. 2015; Chang et al. 2014).”
Hepatoprotective effects of Lactococcus chungangensis CAU 1447 in alcoholic liver disease
Nam, Y., Kim, J., Konkit, M., & Kim, W. (2019) · Journal of Dairy Science · doi:10.3168/jds.2019-16891 · Cited by 11
“Moreover, butyrate suppresses the expression of lipopolysaccharide-induced cytokines (Nastasi et al., 2015).”
BackgroundCarbohydrate-to-Fiber Ratio, a Marker of Dietary Intake, as an Indicator of Depressive Symptoms
Makhani, S. S., Davies, C., George, K., Castro, G., de la Vega, P. R., & Barengo, N. C. (2021) · Cureus · doi:10.7759/cureus.17996 · Cited by 16
“Conversely, they can also enhance an anti-inflammatory response by increasing induction of regulatory T-cell and interleukin (IL)-10 release while decreasing tumor necrosis factor (TNF)-α and interferon (IFN-γ release [38-41].”
Xi, L., Wang, H., Du, J., Liu, A., Wang, J., Ni, Y., Zhang, S., Xie, W., Liu, M., & Wang, C. (2024) · Thrombosis Journal · doi:10.1186/s12959-024-00676-7 · Cited by 12
Communication between gut microbiota-derived metabolites and the tumor microenvironment
Hu, X., Li, B., Li, Y., Liang, Y., & Huang, T. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1649438 · Cited by 11
The role of the microbiota-gut-brain axis in schizophrenia: an immunological perspective
Su, B.-W., Li, Y., Yang, L.-Y., Yang, H., Wang, W., Ren, H., Bao, Y.-N., Lao, J.-Y., & Luan, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1711756 · Cited by 12
The role of gut microbiota in neuropathic pain: insights into immune mechanisms
Gong, Z., Zou, J., Fang, Y., Li, J., Luo, Y., Xue, Q., Yu, B., Hua, B., & Liu, Z. (2025) · The Journal of Headache and Pain · doi:10.1186/s10194-025-02260-4 · Cited by 10
“Similarly, butyrate and propionate have been shown to suppress inflammation by reducing the release of pro-inflammatory factors and inhibiting LPS-induced IL-6 and IL-12 expression in DCs [113].”
InfluentialNi, M., Wang, Z., Li, Z., Chen, M.-J., He, H. F., Cai, H., Chen, Z., Li, M., & Xu, H. (2024) · Animal Research and One Health · doi:10.1002/aro2.71 · Cited by 10
“The anti ‐ inflammatory function of butyrate through its receptor GPR109a has been confirmed in colonic macrophages and dendritic cells (DCs), which subsequently down-regulated the expression of cytokine and chemokine related genes [38, 39].”
The Bright and Dark Sides of Wheat
Boukid, F. (2021) · Springer eBooks · doi:10.1007/978-3-030-69228-5_9 · Cited by 10
Rai, U., Senapati, D., & Arora, M. K. (2022) · Diabetology International · doi:10.1007/s13340-022-00607-9 · Cited by 10
Myhill, L. J., Jensen, P., Zakeri, A., Nielsen, L. F., Jakobsen, S. R., Mejer, H., Thamsborg, S. M., Nejsum, P. L., & Williams, A. R. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.03.006 · Cited by 10
From Gut to Brain: The Impact of Short-Chain Fatty Acids on Brain Cancer
Saadh, M. J., Allela, O. Q. B., Kareem, R. A., Sanghvi, G. V., Menon, S. V., Sharma, P., Tomar, B. S., Sharma, A., Sameer, H. N., Hamad, A. K., et al. (2025) · NeuroMolecular Medicine · doi:10.1007/s12017-025-08830-8 · Cited by 10
“According to these results, both propionate and butyrate treatments have an immunomodulatory effect on m-DC cells (Nastasi et al., 2015).”
Free fatty acid 3 receptor agonist AR420626 reduces allergic responses in asthma and eczema in mice
Lee, Y., Son, S., & Im, D. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111428 · Cited by 12
Ding, Y., Lan, J., Wang, Y., Pan, Y., Song, T., Liu, S., Gu, Z., & Ge, Y. (2025) · npj Science of Food · doi:10.1038/s41538-024-00359-7 · Cited by 11
Huang, D., Ren, Q., Xie, L., Chen, Y., Cui, L., Su, X.-F., Lin, L., Liu, L., Zhao, H., Luo, T., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-86231-4 · Cited by 12
Ramar, M., Wiscovitch-Russo, R. A., Yano, N., Singh, H., Lamere, E., Short, M. P., González-Juarbe, N., & Fedulov, A. V. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115684 · Cited by 9
“Specifically, butyrate and propionate inhibit the production of cytokines in DCs 93,94 ; butyrate induces tolerogenic human DCs 95 and has other prominent effects on DC maturation and function, 96-98 implicating counterinflammatory outcomes, 99-101 including downstream interactions with T cells.”
Microbiota-derived metabolites as modulators of cancer immunotherapy response
Toner-Bartelds, C., Mimpen, I. L., Parra-Martinez, M., Burgering, B. M. T., & Voest, E. E. (2026) · Nature Communications · doi:10.1038/s41467-026-72178-1 · Cited by 10
“Initial evidence came from a study by Nastasi et al., which showed that treating healthy-donor-derived DCs with the SCFAs (diet-microbiota, Box 1) butyrate and propionate in vitro reduced the production of pro-in fl ammatory cytokines and induced an anti-in fl ammatory pro fi le in these cells 23 .”
Shi, H., Yuan, X., Wu, F., Li, X., Fan, W., Yang, X., & Liu, G. (2024) · Aging · doi:10.18632/aging.205417 · Cited by 13
The Role of Gut-derived Short-Chain Fatty Acids in Multiple Sclerosis
Saadh, M. J., Ahmed, H. M., Alani, Z. K., Zuhairi, R. A. H. A., Almarhoon, Z. M., Ahmad, H., Ubaid, M., & Alwan, N. H. (2024) · NeuroMolecular Medicine · doi:10.1007/s12017-024-08783-4 · Cited by 8
“SCFAs, secreted into the gut and distributed through the bloodstream to tissues, exhibit immunomodulatory effects on human DCs, which, as antigen-presenting cells (APCs), shape the immune system's response (Claudia Nastasi et al., 2015).”
Sun, Y., Song, J., Lan, X., Ma, F., Jiang, M., & Jiang, C. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s420689 · Cited by 9
“Nastasi et al found that SCFAs, especially propionic acid, and butyric acid, can inhibit the expressions of cytokines IL-6 and IL-12 induced by LPS in human mature dendritic cells.(42) SCFAs trigger the generation of prostaglandin E2 and the IL-10 levels by stimulating GPCRs, and can also activate inflammasomes, promo…”
BackgroundIncorporating Postbiotics into Intervention for Managing Obesity
Hijová, E., Bertková, I., & Štofilová, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115362 · Cited by 7
“Butyrate and propionate decrease the secretion of pro-inflammatory chemokines and downregulate the expression of cytokines such as interleukin-6 (IL-6) and interleukin-12p40 (IL-12p40), particularly in response to LPS stimulation [95,96].”
Matera, M., Biagioli, V., Illiceto, M. T., Palazzi, C. M., Cavecchia, I., Manzi, A., Lugli, S., Pennazzi, L., Meocci, M., Pedaci, F. A., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1726630 · Cited by 7
“In microglia, SCFAs promote a shift toward an anti-in fl ammatory phenotype and reduce pro-in fl ammatory cytokine production (85 – 90).”
Wang, M., Su, H., & Liu, J. (2025) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2025231 · Cited by 7
Molecular Ensembles of Microbiotic Metabolites in Carcinogenesis
Shatova, O. P., Zabolotneva, A. A., & Shestopalov, A. V. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923070027 · Cited by 9
“[85] showed that butyrate and propionate played a pivotal role in modulating immune response in mature human DCs.”
Background
Metadata
- Authors
- Nastasi, C., Candela, M., Bonefeld, C. M., Geisler, C., Hansen, M., Krejsgaard, T., Biagi, E., Andersen, M. H., Brigidi, P., Ødum, N., Litman, T., & Woetmann, A.
- Affiliations
- University of Copenhagen (DK)
- University of Bologna (IT)
- Herlev Hospital (DK)
- Leo Pharma (Denmark) (DK)
- Corresponding author
- Woetmann, Anders
- ORCID
- Venue
- Scientific Reports
- Published
- 2015-11-06
- Volume
- 5
- Issue
- 1
- Pages
- 16148-16148
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4635422
- OpenAlex
- W2193435259
- Cited by
- 414
- References
- 45
- Citations by year
- 2026: 27 · 2025: 55 · 2024: 48 · 2023: 53 · 2022: 42 · 2021: 50 · 2020: 42 · 2019: 32 · 2018: 20 · 2017: 30 · 2016: 15
- FWCI
- 9.40
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
- Funders
- Kræftens Bekæmpelse
- Lundbeckfonden
- Novo Nordisk Fonden (NNF12OC0002036)
- H. Lundbeck A/S
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- short-chain fatty acids, butyrate, propionate, acetate, monocyte-derived dendritic cells, gut microbiota, host-microbiome interactions, chemokine expression, leukocyte migration, anti-inflammatory activity, interleukin-6, IL-12p40, transcriptional response
- MeSH terms
- Gastrointestinal Microbiome, Butyrates, Cells, Cultured, Dendritic Cells, Fatty Acids, Volatile, Humans, Inflammation, Leukocytes, Lipopolysaccharides, Monocytes, Propionates, Transcription, Genetic, Interleukin-6, Gene Expression, Chemokines, CXC, Interleukin-12 Subunit p40
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.